Zoo Capital Joins Qiming in Eye‑disease Biotech
18 Dec 2025
US$ 20.00
Zoo Capital has participated in the US$30 m series B financing round of Shenzhen Oculgen Biomedical Technology Co ......
Related Publications
Subscribers’ Weekly for the week ending 19 December 2025...
IPOs of Moore Treads and MetaX are powerful signals that China’s AI chip industry is not far from being self-sufficient...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.